【Major Corporate Announcements】China Biologic (01177) has entered into an exclusive licensing agreement with Sanofi for rovatcitinib. Degron Therapeutics (06996) has reached a global exclusive licensing agreement with UCB for ATG-201. Gushengtang (02273) plans to acquire 70% equity stakes in Jinan Xinyangguang, Jinan Yunshengtang, and Jinan Licheng Yunshengtang. Junzhi Group (01300) is pre-qualified as a winning bidder for China Telecom's power cable centralized procurement project for 2025–2027. GigaDevice (03986) intends to invest 400 million yuan to subscribe to shares of Shanghai Shixi GigaDevice ZhiXin Venture Capital Partnership. Kingsoft Cloud (03896)'s subsidiary plans to acquire a 20% stake in Shenzhen Wangxin Technology for 50 million yuan. Youjia Innovation (02431) has formally signed a strategic cooperation agreement with Times Intelligent to jointly develop globally competitive intelligent and electric solutions.

【Financial Results】Techtronic Industries (00669) announced its 2025 financial results, with net profit increasing by 6.8% to $1.2 billion and a final dividend of 132 HK cents per share. MMG (01208) released its annual results, reporting pre-tax profit of $1.727 billion for the year, a 178% year-on-year increase. Great Eagle H (00041) announced annual results, with core profit attributable to equity holders reaching HK$2.0767 billion, up 33.7% year-on-year. ASMPT (00522) reported its 2025 performance, with consolidated profit after tax amounting to HK$902 million, an increase of 163.6% compared to the previous year. Pacific Basin Shipping (02343) released its annual results, with profit attributable to shareholders of $58.2 million, a decrease of 56% year-on-year. TOT Biopharm (01875) achieved operating revenue of approximately 748 million yuan in 2025. Xtalpi (02228) issued a profit alert, expecting both after-tax profit and profit attributable to equity holders to be no less than 100 million yuan for 2025, marking its first full-year profit. H&H Intl Hldg (01112) anticipates adjusted comparable net profit to grow between 15% and 25% for 2025.